. Author manuscript; available in PMC: 2014 Sep 1.

Published in final edited form as: J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):325–333. doi: 10.1177/2325957413491432

Table 5.

Unadjusted and adjusted associations between retinal vasculature measurements and prevalent reported hypertension or use of hypertensive treatment at baseline, participants without ocular opportunistic infections^*

	Unadjusted		Adjusted^**

	Odds Ratio	(95% CI)	Odds Ratio	(95% CI)
Central Retinal Artery Equivalent
1^st vs. 4^th quartile	2.30	(1.55 – 3.43)	2.16	(1.23 – 3.78)
2^nd vs. 4^th quartile	1.80	(1.20 – 2.69)	1.89	(1.14 – 3.15)
3^rd vs. 4^th quartile	1.33	(0.87 – 2.03)	1.08	(0.65 – 1.78)
Central Retinal Vein Equivalent
1^st vs. 4^th quartile	1.48	(1.00 – 2.19)	1.18	(0.68 – 2.07)
2^nd vs. 4^th quartile	1.36	(0.92 – 2.02)	1.11	(0.66 – 1.85)
3^rd vs. 4^th quartile	1.36	(0.92 – 2.02)	1.52	(0.94 – 2.47)

n = 1,255 participants without ocular opportunistic infection and with available retinal vasculature measurements

^**

Adjusted for demographics (age, sex, race, education, insurance status, employment status, weight), HIV characteristics and treatment (HIV risk factor. Time since AIDS diagnosis, CD4+ T-cells: baseline and nadir, HIV viral load: baseline and peak, HAART, PI-based HAART, NNRTI-based HAART) and comorbidities (hyperlipdemia, diabetes and hepatitis C infection: cleared and chronic)